We do have Covid19 IgG/IgM Immunoassay rapid tests to fight the pandemic
0

Your Cart is Empty

MA1059

CRADLE Vital Signs Monitor

Pregnancy-specific handheld semi-automatic vital signs monitor specifically calibrated for use by community health workers to detect signs of preeclampsia, sepsis and shock. Developed by UK hypertension experts and tested in multiple clinical trials, this rugged device is essential for all health workers monitoring antenatal care.

  • Replaces need for blood pressure cuff and stethoscope for those with minimal medical training
  • Traffic signal warnings for SHOCK and high blood pressure (red, orange, green)
  • Identifies shock after hemorrhage and high blood pressure due to eclampsia (2 leading causes of maternal death)

THE PROBLEM

Preeclampsia is persistent high blood pressure that develops during pregnancy or in postpartum. Left untreated, preeclampsia can cause fetal growth restriction, preterm birth, placental abruption, organ damage, seizures, and death. Preeclampsia is the second leading cause of maternal death behind postpartum hemorrhage. Measuring blood pressure for early identification of preeclampsia is challenging in low-resource settings due to lack of training and the financial costs associated with equipment. With 99% of maternal deaths occurring in low- and middle-income countries, it is critical that these areas have affordable, effective, and easy-to-use tools to monitor vitals and respond promptly to signs of preeclampsia.

THE SOLUTION

Tasked with developing a rugged, reliable way to detect preeclampsia in low-resource settings, the King's College blood pressure experts invented and refined this CRADLE device over the course of a decade. The first validated vital signs monitoring device specifically calibrated for use in pregnancy in low-resource settings, the device is used to detect preeclampsia and shock with a unique 'traffic signal' red-orange-green light readout. The device tests both blood pressure and heart rate, giving a reading that tells a community health worker whether to refer the patient (red light), watch the patient (orange light), or keep the patient (green light).  

The device has been tested in rigorous clinical trials and adapted for low- and middle-income countries with a target user being a community health worker. The PREEMPT trials were part of a massive set of community- and facility-level efforts to improve the detection and treatment of preeclampsia in low- and middle-income countries. 

  • Meets WHO guidelines for use in low resource settings
  • Fulfills the standard required by the ANSI/AAMI/ISO protocol.

 

Size

Pregnancy-specific handheld semi-automatic vital signs monitor specifically calibrated for use by community health workers to detect signs of preeclampsia, sepsis and shock. Developed by UK hypertension experts and tested in multiple clinical trials, this rugged device is essential for all health workers monitoring antenatal care.

  • Replaces need for blood pressure cuff and stethoscope for those with minimal medical training
  • Traffic signal warnings for SHOCK and high blood pressure (red, orange, green)
  • Identifies shock after hemorrhage and high blood pressure due to eclampsia (2 leading causes of maternal death)

THE PROBLEM

Preeclampsia is persistent high blood pressure that develops during pregnancy or in postpartum. Left untreated, preeclampsia can cause fetal growth restriction, preterm birth, placental abruption, organ damage, seizures, and death. Preeclampsia is the second leading cause of maternal death behind postpartum hemorrhage. Measuring blood pressure for early identification of preeclampsia is challenging in low-resource settings due to lack of training and the financial costs associated with equipment. With 99% of maternal deaths occurring in low- and middle-income countries, it is critical that these areas have affordable, effective, and easy-to-use tools to monitor vitals and respond promptly to signs of preeclampsia.

THE SOLUTION

Tasked with developing a rugged, reliable way to detect preeclampsia in low-resource settings, the King's College blood pressure experts invented and refined this CRADLE device over the course of a decade. The first validated vital signs monitoring device specifically calibrated for use in pregnancy in low-resource settings, the device is used to detect preeclampsia and shock with a unique 'traffic signal' red-orange-green light readout. The device tests both blood pressure and heart rate, giving a reading that tells a community health worker whether to refer the patient (red light), watch the patient (orange light), or keep the patient (green light).  

The device has been tested in rigorous clinical trials and adapted for low- and middle-income countries with a target user being a community health worker. The PREEMPT trials were part of a massive set of community- and facility-level efforts to improve the detection and treatment of preeclampsia in low- and middle-income countries. 

  • Meets WHO guidelines for use in low resource settings
  • Fulfills the standard required by the ANSI/AAMI/ISO protocol.

 

Customer Reviews

Based on 1 review Write a review
News & Updates

Sign up to get the latest on sales, new releases and more …

maternal and newborn health news